| Financial Year |
March 31 2023 |
| Monetary Funds |
4,802,052,338.39 |
| Held-for-trading Financial Assets |
31,728,405.52 |
| Notes Receivable |
307,586,557.80 |
| Accounts Receivable |
3,064,987,138.34 |
| Advances to Suppliers |
661,311,735.93 |
| Other Receivables |
69,819,652.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,889,308,879.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
235,350,052.77 |
| Total Current Assets |
16,546,922,113.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
119,215,725.73 |
| Investment Properties |
-- |
| Fixed Assetes |
4,618,154,498.42 |
| Under-construction Projects |
2,984,042,292.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
569,158,266.92 |
| R&D expenses |
-- |
| Goodwill |
131,247,741.85 |
| Long-Term Deferred and Prepaid Expenses |
76,879,719.99 |
| Deferred Income Tax Assets |
84,717,353.78 |
| Other Non-Current Assets |
267,962,889.90 |
| Sub-Total of Non-Current Assets |
8,905,781,399.68 |
| Total Assets |
25,452,703,513.25 |
| Short-Term Loans |
1,901,263,952.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,296,376,520.74 |
| Accounts Payable |
2,892,117,410.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,508,854.82 |
| Taxes Payable |
131,363,705.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
94,732,525.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
479,647,464.37 |
| Other Current Liabilities |
4,491,288.19 |
| Sub-Total of Current Liabilities |
12,904,050,093.42 |
| Long-term Loans |
3,462,501,391.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,362,060.38 |
| Special Payable |
-- |
| Estimatied Liabilities |
35,851,499.60 |
| Deferred Income Tax Liabilities |
48,955,428.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,731,714,456.45 |
| Total Liabilities |
16,635,764,549.87 |
| Paid-In Capital(Or Share Stock) |
450,883,265.00 |
| Capital Surplus |
3,925,741,626.23 |
| Surplus Reserve |
40,554,339.70 |
| LESS:Treasury Stock |
87,732,552.36 |
| Undistributed Profits |
2,908,801,748.73 |
| Minority Stockholder's Interest |
1,583,840,547.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,233,098,416.17 |
| Owner's Equity（Stockholder's Equity） |
8,816,938,963.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,452,703,513.25 |
